FACT IEC Quality Webinar: CAR-T Cells and T-Cell Receptor Cells in Solid Tumors

Description:

CAR-T and TCR cell therapy has demonstrated encouraging potential for the treatment of solid tumors. During this webinar, presenters will highlight current clinical experience with CAR-T cells in solid tumors and unique considerations in manufacturing. Presenters will also discuss the need for establishing safety and efficacy quality benchmarks for CAR-T cells and TCRs. Presenters include: • Matthew Frigault, MD, from Massachusetts General • Partow Kebriaei, MD, from the University of Texas MD Anderson Cancer Center At the conclusion of this activity, participants will be able to: • Identify the similarities and differences between CAR-T and TCR-platforms • Recognize the unique challenges in manufacturing of CAR-T and TCR cells for solid tumors • Recognize the need for establishing safety and efficacy quality benchmarks for CAR-T and TCR and understand how FACT can help